Please ensure Javascript is enabled for purposes of website accessibility

Why Pot Stocks Led Markets Higher Into the Holiday Weekend

By Dan Caplinger - May 28, 2021 at 5:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wall Street closed the month on a positive note.

The stock market closed the week on an up note, finishing the month of May as Monday brings the Memorial Day holiday. Gains were modest, but the Dow Jones Industrial Average (^DJI -0.86%), S&P 500 (^GSPC -1.29%), and Nasdaq Composite (^IXIC -2.01%) all managed to climb higher.

Index

Percentage Change

Point Change

Dow

+0.19%

+65

S&P 500

+0.08%

+3

Nasdaq Composite

+0.09%

+12

Data source: Yahoo! Finance.

Some of the biggest movers on Friday were marijuana stocks. Investors have been generally excited about the prospects for the cannabis industry since the U.S. elections, but the downturn in high-growth stocks also brought that positive momentum for pot investments to a halt. Now, it appears that investors have high hopes for the future once again. Let's look at some of the stocks seeing the biggest gains.

Cannabis leaf on top of a pile of leaves.

Image source: Getty Images.

Nearly unanimous gains for the marijuana industry

Much of the cannabis sector enjoyed considerable gains on Friday. The ETFMG Alternative Harvest ETF (MJ -3.21%), which includes a wide array of cannabis-related investments, rose nearly 2% in the session.

Major cannabis stocks were up even more sharply, with one exception. Cronos Group (CRON -4.54%) led the way with a 15% rise, while Aurora Cannabis (ACB -7.27%) gained 8% and Canopy Growth (CGC 0.26%) was higher by nearly 6%. Only Tilray (TLRY -7.20%) missed out on the gains, with a drop of 3% coming in the last 30 minutes of the trading day.

Some smaller players in the marijuana space did equally well. Crowd favorite Sundial Growers (SNDL 0.35%) picked up almost 15%, while HEXO (HEXO -5.98%) was higher by 10%. OrganiGram Holdings (OGI -6.36%) saw its stock jump 11%.

Why was pot on the rise?

A number of factors supported the increase in investor interest in cannabis stocks. First, most of the top stocks in the sector are based in Canada and rely heavily on the Canadian retail market currently. The pandemic has been more stubborn north of the U.S. border, as vaccine rollouts have been somewhat slower. However, the country is making greater progress, and with the prospects of restrictions finally getting lifted, investors are hoping for a boost for the industry domestically.

Also, companies are getting more aggressive about consolidation efforts. Tilray's acquisition of Aphria is perhaps the clearest example, but today, HEXO announced that it would make its own strategic move, spending $765 million to buy out cannabis producer Redecan. Once the deal goes through, HEXO would become an industry leader in dried flower as well as in cannabis-infused beverages. Shareholders can expect some dilution, but only between 50% and 60% of the total price will come from new stock, with HEXO paying $330 million in cash.

Finally, marijuana investors still believe that the U.S. market is ripe for picking once the federal government makes moves to decriminalize pot. There hasn't been much progress on that front since January, as lawmakers have focused on different issues. Nevertheless, many in the industry see it as simply a matter of time before would-be cannabis consumers in the U.S. have the same ability to buy nationwide as their Canadian counterparts.

Keep your eyes on cannabis

Pot stocks have already enjoyed huge gains, with many having doubled or more in the past year. However, most are far below their highs from 2018. With growth investors looking for companies that can live up to their long-term potential, marijuana might represent a rare value opportunity amid high-priced high-growth stocks in other areas like technology.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool recommends HEXO Corp. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

HEXO Stock Quote
HEXO
HEXO
$0.22 (-5.98%) $0.01
Dow Jones Industrial Average (Price Return) Stock Quote
Dow Jones Industrial Average (Price Return)
^DJI
$33,706.74 (-0.86%) $-292.30
S&P 500 Index - Price Return (USD) Stock Quote
S&P 500 Index - Price Return (USD)
^GSPC
$4,228.48 (-1.29%) $-55.26
NASDAQ Composite Index (Price Return) Stock Quote
NASDAQ Composite Index (Price Return)
^IXIC
$12,705.22 (-2.01%) $-260.13
Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$1.53 (-7.27%) $0.12
Canopy Growth Stock Quote
Canopy Growth
CGC
$3.82 (0.26%) $0.01
OrganiGram Holdings Stock Quote
OrganiGram Holdings
OGI
$1.03 (-6.36%) $0.07
Cronos Group Stock Quote
Cronos Group
CRON
$2.94 (-4.54%) $0.14
ETF Managers Trust - ETFMG Alternative Harvest ETF Stock Quote
ETF Managers Trust - ETFMG Alternative Harvest ETF
MJ
$6.02 (-3.21%) $0.20
SNDL Inc. Stock Quote
SNDL Inc.
SNDL
$2.90 (0.35%) $0.01
Tilray Stock Quote
Tilray
TLRY
$3.74 (-7.20%) $0.29

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
397%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.